26 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
to identify director candidates, including sole authority to approve fees and other terms of the retention;
annually assessing the performance
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
to be used to identify director candidates, including sole authority to approve fees and other terms of the retention;
annually assessing the performance
6-K
EX-99.2
XRTX
XORTX Therapeutics Inc
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
is to provide a combination of short, medium and long term incentives that reward performance and also are designed to achieve retention of high-quality … remuneration standpoint and to encourage executive officer retention.
Annual and special incentive stock option awards granted as determined by the Board
6-K
EX-99.3
5n3jsyf2
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
330ed
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
0vtczk7078jr
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
pyibb69
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
q2ig5nad3 2zf
8 Sep 22
Registration statement (foreign)
1:02pm
F-1
EX-1.1
9nd3o 35w
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
t24md5keomk2bgdb9y14
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
txki3kda
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
EX-15.2
40gvu ks4woy99ysgt
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.22
4pzqfhr1vwdam
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.17
xe0s dtafeu0w
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.25
mnd3y67su1zj02 80
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.20
wezjh7uq9frrzr2iubmq
3 May 22
Annual report (foreign)
5:29pm
20-F
cexdz7epyzeetu4j
3 May 22
Annual report (foreign)
5:29pm